Metraipolis › archive › dc_70691bdadd59

Effectiveness of indacaterol/glycopyrronium/mometasone for refractory asthmatic cough after switching from inhaled corticosteroid/long-acting β2-agonist therapy — Europe PMC PMID:41113250

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41113250
DOI
10.1016/j.jacig.2025.100567
License (as archived)
solo-consultazione
Archived
2026-11-10T02:04:57.002Z
SHA-256 of the archived text
90bc3d131be7b36d7a5497a88187239698b80de734e4054d8433a70a5239ec47
Stable URL of this page
https://metraipolis.com/documento/dc_70691bdadd59

How to cite

Effectiveness of indacaterol/glycopyrronium/mometasone for refractory asthmatic cough after switching from inhaled corticosteroid/long-acting β2-agonist therapy — Europe PMC PMID:41113250 — Europe PMC (en), https://europepmc.org/article/MED/41113250 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_70691bdadd59 (Metraipolis archive dc_70691bdadd59, sha256 90bc3d131be7b36d7a5497a88187239698b80de734e4054d8433a70a5239ec47)
BibTeX
@misc{dc70691bdadd59,
  title = {Effectiveness of indacaterol/glycopyrronium/mometasone for refractory asthmatic cough after switching from inhaled corticosteroid/long-acting β2-agonist therapy — Europe PMC PMID:41113250},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41113250},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_70691bdadd59; sha256 90bc3d131be7b36d7a5497a88187239698b80de734e4054d8433a70a5239ec47},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41113250. Agents can read the archived copy with the MCP tool read_document.